Research workbench
Crystal structure of the the CD9
Analyse Crystal structure of the the CD9 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 6K4J
- Type
- protein
- Length
- 220 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- CD9 antigen
- UniProt
- P21926
- Ligands
- PLM, NI
- Pockets
- 3 · best druggability 0.53
Structure
x-ray diffraction · 1 distinct chain · 79% helix, 1% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | CD9 antigen | protein | 220 | 79% helix, 1% strand | P21926 |
Ligands and binding sites
- PLM · Palmitic acid · ligand · chains A
- NI · Nickel (II) ion · metal · chains A
- OLC · (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 162 | 0.53 | 0.78 | 19 | empty |
| 2 | 112 | 0.46 | 0.78 | 21 | empty |
| 3 | 61 | 0.27 | 0.72 | 12 | empty |
Modifications
Observed in the structure: 2 disulfide, 1 lipid (disulfide, palmitoylation).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P21926
- Elsewhere: RCSB PDB 6K4J · PDBe 6K4J · UniProt P21926
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.